Virtus ETF Advisers’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,799
Closed -$47.1K 373
2024
Q4
$47.1K Buy
+8,799
New +$47.1K 0.02% 459